These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 24703963

  • 1. Comparision of secretagogue effects of rosiglitazone and telmisartan on ANP secretion in rats.
    Gao S, Park BM, Cha SA, Kim SZ, Kim SH.
    Peptides; 2014 Jun; 56():52-8. PubMed ID: 24703963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor.
    Yu L, Yuan K, Phuong HT, Park BM, Kim SH.
    Peptides; 2016 Dec; 86():33-41. PubMed ID: 27660028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway.
    Oh YB, Gao S, Shah A, Kim JH, Park WH, Kim SH.
    Peptides; 2011 Feb; 32(2):374-81. PubMed ID: 21056071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.
    Nakano A, Hattori Y, Aoki C, Jojima T, Kasai K.
    Hypertens Res; 2009 Sep; 32(9):765-9. PubMed ID: 19590508
    [Abstract] [Full Text] [Related]

  • 20. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
    Sugimoto K, Kazdová L, Qi NR, Hyakukoku M, Kren V, Simáková M, Zídek V, Kurtz TW, Pravenec M.
    J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.